


progenra.com
Get leads like Progenra — and thousands more
Build targeted lists by tech stack, traffic, and more
Progenra: The Tiny Biotech Targeting Parkinson's
A 12-person team taking on the ubiquitin proteasome system with $1.9M in revenue
In a biotech landscape dominated by billion-dollar IPOs and sprawling pharmaceutical giants, Progenra operates with surgical precision. This 12-person team has quietly carved out a niche in the ubiquitin proteasome system—a complex cellular mechanism that could unlock new treatments for Parkinson's disease.
"They're not playing the venture capital lottery—they're building revenue while cracking one of neurodegeneration's hardest problems."
The Ubiquitin Play
Progenra isn't chasing the latest CRISPR headlines or mRNA hype. Their focus is the ubiquitin proteasome system—the cell's quality control machinery that tags and destroys damaged proteins. When this system fails, misfolded proteins accumulate, leading to Parkinson's and other neurodegenerative diseases. Their strategy: develop Parkin activators that boost this system's natural cleanup function. It's elegant, targeted, and scientifically rigorous.
Funding Without Frenzy
The Michael J. Fox Foundation backing their Parkin activator research validates their approach. But here's what's interesting: with $1.9M in revenue and no disclosed VC funding, they're likely generating income through partnerships or early-stage collaborations. This isn't a company burning cash on animal models and PR—they're monetizing their medicinal chemistry expertise while advancing their pipeline. For investors, this signals discipline. For founders, it's a masterclass in capital efficiency.
- President & CEO Tauseef Butt leads a lean, chemistry-heavy team
- Published in ACS 2019 Medicinal Chemistry Reviews—academic credibility matters
- Heavy Twitter/X presence suggests active scientific engagement
- 73% direct traffic indicates a small, highly engaged audience
The traffic data reveals everything about their stage: 1,018 monthly visits with 73% direct traffic means this isn't a company playing SEO games. Their audience is precise—researchers, potential partners, and the neurodegeneration community. The top search term is a typo of their own domain name, which either speaks to brand recall or a fascinating SEO problem they haven't solved yet. Either way, they're not optimizing for scale—they're optimizing for science.
The Anti-Biotech Biotech
12 people, $1.9M revenue, one mission: crack the ubiquitin code for Parkinson's. No hype, just chemistry.
What tech stack does Progenra use?
How much traffic does Progenra get?
Traffic & Engagement
Traffic Sources
Where is Progenra's audience located?
What keywords does Progenra rank for?
5 keywordsHow is Progenra's SEO?
Open Graph Image

https://progenra.com/wp-content/uploads/2025/05/approval_hires.png
Meta Tags
Home | Progenra
Home | Progenra - Dedicated to Finding New Medicines Through Targeting the Ubiquitin Proteasome System to fill unmet needs in a spectrum of therapeutic areas.
H1 Tags
Schema Types
What is Progenra's revenue?
Who works at Progenra?
Loading leads...
What do customers think of Progenra?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Progenra
What is Progenra's Revenue?
What does Progenra do?
How fast is Progenra growing?
What technologies does Progenra use?
Who are Progenra's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Progenra?
Contact Information
Export progenra.com Data
Download the complete tech stack, analytics, leads, and company data for progenra.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About progenra.com
Home | Progenra - Dedicated to Finding New Medicines Through Targeting the Ubiquitin Proteasome System to fill unmet needs in a spectrum of therapeutic areas.
Company Overview
progenra.com Social Media
Contact progenra.com
Email Addresses
Phone Numbers
Technology Stack
progenra.com uses 16 technologies across their website including Font Awesome, PHP, WordPress, and more.
Fonts
Font Awesome
Programming Languages
PHP
CMS
WordPress
Analytics & Marketing
Google Analytics
Performance
Lazy Loading, Priority Hints
Web Standards
Twitter Cards, RSS, PWA
Traffic & Audience
progenra.com receives approximately 1.0K monthly visitors and ranks #14,273,914 globally. The website has a bounce rate of 39% with visitors viewing an average of 1.1 pages per visit. Users spend an average of 0:00 on the site.
The majority of progenra.com's traffic comes from .
Frequently Asked Questions
What is progenra.com?
What technologies does progenra.com use?
How do I contact progenra.com?
What are progenra.com's social media accounts?
How popular is progenra.com?
Related Searches
This page provides publicly available information about progenra.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit progenra.com directly at https://progenra.com.